Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment
- PMID: 8796568
- DOI: 10.1016/s1076-6332(96)80542-3
Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment
Similar articles
-
Preparation, characterization, and evaluation of ioxilan carbonate particles for computed tomography contrast enhancement of liver.Invest Radiol. 1994 Nov;29(11):1006-13. doi: 10.1097/00004424-199411000-00010. Invest Radiol. 1994. PMID: 7890508
-
Biodistribution of cyclic carbonate of ioxilan: a radiopaque particulate macrophage imaging agent.Acad Radiol. 1996 Jun;3(6):500-6. doi: 10.1016/s1076-6332(96)80010-9. Acad Radiol. 1996. PMID: 8796708
-
Urine profiles following intravenous diatrizoate, iohexol, or ioxilan in rats.Invest Radiol. 1988 Sep;23 Suppl 1:S168-70. doi: 10.1097/00004424-198809001-00028. Invest Radiol. 1988. PMID: 3198338
-
Preclinical characterization of iopromide.Invest Radiol. 1994 May;29 Suppl 1:S21-32. doi: 10.1097/00004424-199405001-00005. Invest Radiol. 1994. PMID: 8071040 Review. No abstract available.
-
Ioxilan carbonate particles.2007 Sep 1 [updated 2007 Dec 18]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Sep 1 [updated 2007 Dec 18]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641969 Free Books & Documents. Review.